Pioneering a Safer, More Advanced Aesthetic Medicine
At The Forefront Of Innovation Since 2003
Celebrating our milestones in aesthetic medicine, our timeline reflects Teoxane's dedication to evolving the industry and enhancing safety through clinical excellence and medical education. Discover how our consistent efforts have contributed to industry advancements for the sake of patients and practitioners alike.
Mrs. Valérie Taupin founds Teoxane Laboratories in Geneva, Switzerland.
Amidst the new emerging market of hyaluronic acid-based filling products.
TEOSYAL® ULTRA DEEP1, the 1st Volumizer to be injected with a fine needle.** & TEOSYAL KISS®, the 1st hyaluronic acid filler dedicated to lips2**
Creation of Teoxane Dermocosmetics3
The first to evolved crosslinked hyaluronic acid similar to dermal-fillers into a dermocosmetics portfolio as an at-home skincare solution.4
Launch of Teosyal® PURESENSE Redensity 2
The first and only company in the world to create a dermal filler designed specifically for the sensitive and delicate Tear Trough area. 5-7
Launch of Teosyal® PURESENSE Redensity 18
A unique “beauty booster”.9
Launch of our groundbreaking TEOSYAL RHA® line
The first range of HA dermal fillers that moves with and adapts to our facial expressions, for a more natural look and feel. 10
Approval by the FDA of RHA® 2, RHA® 3, RHA® 4
The first and only FDA- approved hyaluronic-based fillers for dynamic wrinkles and folds. 11
Opening of the Teoxane Academy in Geneva
Launch of the Lip Unique Collection
The first entire collection of 5 products suitable for treatment of the lips, because we know that every smile is unique.
Creation of Teoxane’s signature “ATP” approach
The first brand systematic medical approach grounded on the philosophy of “facial anatomy”,” techniques” and “science of products” to deliver best-in-class and evidence-based education & treatments in order to individualize the assessment of the face.12
Approval by the FDA of RHA® Redensity
U.S. FDA approval for RHA® Redensity’s first indication, which is for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in adults aged 22 or older.
30 million syringes sold worldwide13
Teoxane Achieves MDR Certification for TEOSYAL® PureSense and TEOSYAL RHA®
